FDA Approves Amylin's Diabetes Drug

January 27, 2012, 7:49 am by Wall Street Journal

The FDA approved Amylin Pharmaceuticals' diabetes drug Bydureon after a prolonged regulatory process to address safety concerns.

Read the full article

More from Wall Street Journal

Panel Backs Weight-Loss Drug Qnexa
Wall Street Journal : February 22, 2012, 5:10 am
An FDA panel backed Vivus's Qnexa, which could lead to approval of the first new prescription weight-loss drug in more than a decade.

More Suppliers Linked to Heparin Contamination
Wall Street Journal : February 22, 2012, 4:58 am
The FDA found 14 additional Chinese companies were supplying contaminated raw material to make heparin, a widely used blood thinner.

FDA to Boost Supply of Cancer Drugs
Wall Street Journal : February 21, 2012, 11:49 am
The FDA approved two new suppliers of two cancer drugs that are currently in short supply.

Justices Reject J&J Bid to Save Patent Case
Wall Street Journal : February 21, 2012, 10:58 am
The U.S. Supreme Court refused to consider a J&J subsidiary's bid to save its patent lawsuit targeting Abbott Laboratories' treatment for rheumatoid arthritis.

J&J CEO Weldon Is Out
Wall Street Journal : February 21, 2012, 10:19 am
Johnson & Johnson picked Alex Gorsky to be its next chief executive. He will take over from longtime leader William Weldon in April.